AD-209

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AD-209, covering 2021-07-21 to 2024-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of AD-209 [Phase 3]